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To the Editor
Global vaccination of children has dramatically reduced the incidence of illness and deaths 
from Bordetella pertussis, the causative agent of whooping cough. However, increased cases 
of whooping cough have recently been reported in several countries including the US. While 
there has been much attention given to waning immunity associated with the introduction of 
acellular vaccines1, another factor contributing to the outbreaks may be adaptation of B. 
pertussis to vaccine selection pressure. Pertactin (prn) is a component of acellular vaccines. 
Pertactin-negative variants of B. pertussis have recently been reported in clinical isolates 
from Japan, France and Finland. The variants from Japan and Finland had deletions or 
insertion sequences in the prn1 allele; the French isolates had deletions or truncations in the 
prn2 allele.2,3 Pertactin mutants retain lethality in mouse models of infection and are 
transmissible in humans.2
We analyzed the pertactin genes from twelve isolates of B. pertussis cultured from children 
hospitalized in Philadelphia during 2011–12 (Table 1). The entire coding region for pertactin 
was amplified and sequenced.3,4 PFGE was performed with XbaI as the restriction enzyme.4 
The PFGE profiles were determined using the CDC database for US isolates. For Western 
blots, pertactin was detected using anti-69K antiserum (NIBSC#97/558) with WHO strain 
18323 serving as the pertactin-positive reference strain.
By Western blot, eleven of the twelve B. pertussis isolates were negative for pertactin. 
Sequencing revealed that four of these isolates had insertion sequence IS481 disrupting the 
pertactin coding region and seven had a stop codon truncating the protein. By PFGE typing, 
three isolates with IS481 inserted at nucleotide 1613 were identical. The seven isolates with 
the stop codon at amino acid position 425 were identical or >92% related. The pertactin 
allele in all 12 isolates was prn2; mutations were different from the pertactin-negative prn2 
isolates from France. In the US, prn2 has been predominant pertactin allele since the 
1990s. 5 However, multilocus sequence typing used to determine pertactin allele types would 
not have detected these variants, as the mutations were outside of the sequenced region.
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To our knowledge, this represents the first reported occurrence of pertactin-negative variants 
of B. pertussis in the US. Isolates of B. pertussis from geographically-distinct regions in the 
US should be evaluated to determine if our finding is a local event or represents a more 
widespread shift in B. pertussis strains. Understanding of the epidemiology and virulence of 
pertactin-negative variants is crucial to developing optimized pertussis vaccines.
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